Search results
Found 547 matches for
The partnership deal, worth over €876M, will enable Enara Bio to lead the discovery and validation of Dark Antigens to target lung and gastrointestinal cancers.
"We loved being in the BioEscalator, and part of the community, and the support and flexibility from the BioEscalator team was invaluable."
Hollie Coe, Base Genomics (now Exact Sciences Innovation)
"The high-quality facilities, resources and support to grow a company were invaluable."
Tim Funnell, MiroBio (now Gilead)
